| 8:00am |
Registration Opens |
| 9:00am |
Welcoming Remarks & Opening Plenary Session: Creating Value Through Strategic Partnerships
Suite 200
Moderator: Christine Fischette, PhD, CEO, BioLinkUp LLC
- Rana Al-Hallaq, PhD, Executive Director, WWBD; Partner, Pfizer Ventures
- Eva Chmielnicki, PhD, Senior Director, Business Development, Bristol Myers Squibb
- Kevin Sharpe, PhD, Director, Oncology Business Development, Merck
- Debi Watson, Vice President, Venture Investments, Johnson & Johnson Innovation – JJDC
|
|
10:00am
|
Emerging Company Showcase – Session 1
Suite 201
- 10:00 AM: Sagittarius Bio, Inc
- 10:15 AM: POP Biotechnology
- 10:30 AM: UnandUP
- 10:45 AM: Helex
|
| 10:00am |
Emerging Company Showcase – Session 2
Suite 203
- 10:00am -Novomedix, LLC
- 10:15 AM: Synthis Therapeutics
- 10:30 AM: OncoPrecision
- 10:45 AM: Pannex Therapeutics
|
| 10:00am-12:00pm |
Partnering Forum |
| 11:00am |
Emerging Company Showcase – Session 3
Suite 201
- 11:00am: Vivreon Biosciences, LLC
- 11:15 AM: Dignify Therapeutics, LLC
- 11:30 AM: ProJenX
|
| 11:00am |
Emerging Company Showcase – Session 4
Suite 201
- 11:00am: Phoenix Nest Inc
- 11:15 AM: Neurodon Corporation
- 11:30 AM: Omnitia Therapeutics
- 11:45 AM: CytoDel, Inc
|
| 12:00pm |
Luncheon & CEO Roundtable: Good Times, Bad Times: The Only Way Out is Through
Suite 200
Moderator: Derek Brand, MBA, Executive Director, Strategic Partnerships, Columbia University
- Dawn Bell, PharmD, CEO, Board Director, Global Biopharma Leader
- Laurence Blumberg, MD, Biotechnology Executive
- Sam Hall, PhD, Life Sciences Venture Investor & Entrepreneur
|
| 1:15pm |
Emerging Company Showcase – Session 5
Suite 201
- 1:15 PM: EicOsis, LLC
- 1:30 PM: Epiodyne, Inc.
- 1:45 PM: Kannalife, Inc.
- 2:00 PM: Microvascular Therapeutics
|
| 1:15pm |
Emerging Company Showcase – Session 6
Suite 203
- 1:15 PM: RNA Nanotherapeutics
- 1:30 PM: Cayuga Biotech
- 1:45 PM: RenBio
- 2:00 PM: MiTOMED Pharma Inc.
|
| 1:15pm |
Partnering Forum
|
| 2:15pm |
Plenary: It’s Never Too Early for Great Science; An Investor Perspective on Building Companies
Moderator: Michael Glynn, PhD, Partner, Fox Rothschild LLP
- Peter Alff, PhD, Senior Venture Partner, Orange Grove Bio
- Cat Donaldson, PhD, MBA, Principal & Head, Alexandria LaunchLabs at ACLS – NYC
- Sanford J. Madigan, PhD, Managing Partner, Avalon BioVentures
- John Prufeta, Founder, CEO & General Partner, Medical Excellence Capital, LLC
|
| 3:15pm |
Emerging Company Showcase – Session 7
Suite 201
- 3:15 PM: 7 Hills Pharma, LLC
- 3:30 PM: Arpeggio Biosciences
- 3:45 PM: DAYI Therapeutics
- 4:00 PM: Nobias Therapeutics
|
| 3:15pm |
Emerging Company Showcase – Session 8
Suite 203
- 3:15 PM: Lime Therapeutics
- 3:30 PM: Kuda Therapeutics, Inc
- 3:45 PM: Tezcat Biosciences
- 4:00 PM: Stingray Therapeutics, Inc.
|
| 4:15pm |
Closing Plenary Session: Markets, Strategies, and Externalities: A Venture Capital Perspective
Suite 200
Moderator: Nathan Meaux, Head of Northeast Biopharma, Diagnostics and Tools – Relationship Management, Silicon Valley Bank
- Rana Al-Hallaq, PhD, Executive Director, WWBD; Partner, Pfizer Ventures
- Dawn Bell, PharmD, CEO/Board Director/Global Biopharma Leader
- Chris Liu, PhD, Senior Research Analyst, RTW Investments, LP
- Jonathan Mandelbaum, PhD, Vice President, OrbiMed
- Nadim Shohdy, PhD, VP, Corporate Development, Hyku Biosciences; Former Entrepreneur-in-Residence, RA Capital
|
| 5:30pm |
Networking Reception
|
